The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The endocannabinoid system in obesity and type 2 diabetes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392 · cited 1×
“The RIO-Lipids trial specifically examined the effects of rimonabant on metabolic risk factors, including adiponectin levels [72].”
BackgroundPi-Sunyer, F. X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & RIO-North America Study Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,218
Cota, D., Marsicano, G., Tschöp, M., Grübler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thöne-Reineke, C., Ortmann, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17725 · Cited by 1,168
Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523057 · Cited by 1,101
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097 · cited 1×
“The data have been subject to different interpretations [78, 80], but clearly point to depressive disorders, nausea, anxiety and dizziness as the most frequent side effects leading to discontinuation.”
BackgroundThe endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. W. (2007) · BMJ · doi:10.1136/bmj.39385.413113.25 · Cited by 801
Di, S., Malcher-Lopes, R., Halmos, K. C., & Tasker, J. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04850.2003 · Cited by 801
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Self-citationKirkham, T. C., Williams, C. M., Fezza, F., & Marzo, V. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704767 · Cited by 788
Scheen, A. J., Finer, N., Hollander, P., Jensen, M. D., & Van Gaal, L. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 736
Activation of the peripheral endocannabinoid system in human obesity
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686 · cited 4×
“Evidence in humans The first evidence of peripheral elevation of EC tone in humans came from studies in overweight/obese women with a binge eating disorder [51] and in obese postmenopausal women [52], in whom elevated blood levels of anandamide only, or both anandamide and 2-AG, respectively, were reported.”
BackgroundInfluentialMatias, I., Gonthier, M.-P., Orlando, P., Martiadis, V., De Petrocellis, L., Cervino, C., Petrosino, S., Hoareau, L., Festy, F., Pasquali, R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2679 · Cited by 656
Self-citationPharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Bensaid, M., Gary-Bobo, M., Esclangon, A., Maffrand, J. P., Le Fur, G., Oury-Donat, F., & Soubrié, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.908 · Cited by 593
Ravinet Trillou, C., Delgorge, C., Menet, C., Arnone, M., & Soubrié, P. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802583 · Cited by 583
Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity
Blüher, M., Engeli, S., Klöting, N., Berndt, J., Fasshauer, M., Bátkai, S., Pacher, P., Schön, M. R., Jordan, J., & Stumvoll, M. (2006) · Diabetes · doi:10.2337/db06-0812 · Cited by 530
Kola, B., Hubina, E., Tucci, S. A., Kirkham, T. C., Garcia, E. A., Mitchell, S. E., Williams, L. M., Hawley, S. A., Hardie, D. G., Grossman, A. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500175200 · Cited by 472
Zhang, L. L., Yan Liu, D., Ma, L. Q., Luo, Z. D., Cao, T. B., Zhong, J., Yan, Z. C., Wang, L. J., Zhao, Z. G., Zhu, S. J., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000262653.84850.8b · Cited by 407
Biochemistry and pharmacology of endovanilloids
Starowicz, K., Nigam, S., & Di Marzo, V. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.005 · Cited by 383
Self-citationCôté, M., Matias, I., Lemieux, I., Petrosino, S., Alméras, N., Després, J.-P., & Di Marzo, V (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803539 · Cited by 383
Self-citationEndocannabinoids and the control of energy balance
Matias, I., & Di Marzo, V. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.11.006 · Cited by 365
Self-citationMarsicano, G., Moosmann, B., Hermann, H., Lutz, B., & Behl, C. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00716.x · Cited by 315
Liu, Y. L., Connoley, I. P., Wilson, C. A., & Stock, M. J. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802847 · Cited by 313
Gary-Bobo, M., Elachouri, G., Gallas, J. F., Janiak, P., Marini, P., Ravinet-Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., et al. (2007) · Hepatology · doi:10.1002/hep.21641 · Cited by 304
Multiple pathways involved in the biosynthesis of anandamide
Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H.-Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.020 · Cited by 304
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Maccarrone, M., Rossi, S., Bari, M., De Chiara, V., Fezza, F., Musella, A., Gasperi, V., Prosperetti, C., Bernardi, G., Finazzi-Agrò, A., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2042 · Cited by 295
Endocannabinoids and the regulation of their levels in health and disease
Di Marzo, V., & Petrosino, S. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32803dbdec · Cited by 289
Self-citationMonteleone, P., Matias, I., Martiadis, V., De Petrocellis, L., Maj, M., & Di Marzo, V. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300695 · Cited by 271
Self-citationOverweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
Sipe, J. C., Waalen, J., Gerber, A., & Beutler, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802954 · Cited by 259
Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
Juan-Picó, P., Fuentes, E., Javier Bermúdez-Silva, F., Javier Díaz-Molina, F., Ripoll, C., Rodríguez de Fonseca, F., & Nadal, A. (2006) · Cell Calcium · doi:10.1016/j.ceca.2005.10.005 · Cited by 258
Rademacher, D. J., Meier, S. E., Shi, L., Vanessa Ho, W.-S., Jarrahian, A., & Hillard, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.012 · Cited by 233 · cited 1×
“this being one of the mechanisms that helps the organism to cope with, and recover from, the consequences of stress [11– 15].”
BackgroundSimon, G. M., & Cravatt, B. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707807200 · Cited by 228
Endocannabinoid mechanisms of pain modulation
Hohmann, A. G., & Suplita, R. L. (2006) · The AAPS Journal · doi:10.1208/aapsj080479 · Cited by 212
Pagano, C., Pilon, C., Calcagno, A., Urbanet, R., Rossato, M., Milan, G., Bianchi, K., Rizzuto, R., Bernante, P., Federspil, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0768 · Cited by 210
The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile
Poirier, B., Bidouard, J. ‐., Cadrouvele, C., Marniquet, X., Staels, B., O'Connor, S. E., Janiak, P., & Herbert, J. ‐. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00374.x · Cited by 203
Van Gaal, L., Pi-Sunyer, X., Després, J.-P., McCarthy, C., & Scheen, A. (2008) · Diabetes Care · doi:10.2337/dc08-s258 · Cited by 199
Addy, C., Wright, H., Van Laere, K., Gantz, I., Erondu, N., Musser, B. J., Lu, K., Yuan, J., Sanabria-Bohórquez, S. M., Stoch, A., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.012 · Cited by 198
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High‐fat Diet
Starowicz, K. M., Cristino, L., Matias, I., Capasso, R., Racioppi, A., Izzo, A. A., & Di Marzo, V. (2008) · Obesity · doi:10.1038/oby.2007.106 · Cited by 194
Self-citationPresence of functional cannabinoid receptors in human endocrine pancreas
Bermúdez-Silva, F. J., Suárez, J., Baixeras, E., Cobo, N., Bautista, D., Cuesta-Muñoz, A. L., Fuentes, E., Juan-Pico, P., Castro, M. J., Milman, G., et al. (2008) · Diabetologia · doi:10.1007/s00125-007-0890-y · Cited by 191
Akiba, Y., Kato, S., Katsube, K.-I., Nakamura, M., Takeuchi, K., Ishii, H., & Hibi, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.149 · Cited by 188
The expression of receptors for endocannabinoids in human and rodent skeletal muscle
Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Janovská, A., Game, P., & Wittert, G. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.099 · Cited by 177
Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’
Di Marzo, V., & Fontana, A. (1995) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90077-2 · Cited by 170
Self-citationPresence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes
Roche, R., Hoareau, L., Bes-Houtmann, S., Gonthier, M.-P., Laborde, C., Baron, J.-F., Haffaf, Y., Cesari, M., & Festy, F. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0127-4 · Cited by 166
Gary‐Bobo, M., Elachouri, G., Scatton, B., Fur, G. L., Oury-Donat, F., & Bensaïd, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015040 · Cited by 160
Matias, I., Petrosino, S., Racioppi, A., Capasso, R., Izzo, A. A., & Di Marzo, V. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.026 · Cited by 159
Self-citationImpaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice
Steiner, M. A., Wanisch, K., Monory, K., Marsicano, G., Borroni, E., Bächli, H., Holsboer, F., Lutz, B., & Wotjak, C. T. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500466 · Cited by 144
Effects of cannabinoid receptors on skeletal muscle oxidative pathways
Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Cameron‐Smith, D., & Wittert, G. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.038 · Cited by 142
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake
Gasperi, V., Fezza, F., Pasquariello, N., Bari, M., Oddi, S., Finazzi‐Agrò, A., & Maccarrone, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6445-4 · Cited by 136
Janiak, P., Poirier, B., Bidouard, J., Cadrouvele, C., Pierre, F., Gouraud, L., Barbosa, I., Dedio, J., Maffrand, J., Fur, G. L., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002540 · Cited by 128
Benzinou, M., Chèvre, J.-C., Ward, K. J., Lecœur, C., Dina, C., Lobbens, S., Durand, E., Delplanque, J., Horber, F., Heude, B., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn089 · Cited by 124
Matias, I., Carta, G., Murru, E., Petrosino, S., Banni, S., & Marzo, V. D. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.11.001 · Cited by 121
Role of cannabinoid CB2 receptors in glucose homeostasis in rats
Bermúdez‐Silva, F. J., Sánchez-Vera, I., Suárez, J., Serrano, A., Fuentes, E., Juan-Picó, P., Nadal, Á., & de Fonseca, F. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.066 · Cited by 120
D'Eon, T. M., Pierce, K. A., Roix, J. J., Tyler, A., Chen, H., & Teixeira, S. R. (2008) · Diabetes · doi:10.2337/db07-1186 · Cited by 119
Nakata, M., & Yada, T. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.009 · Cited by 114
Russo, P., Strazzullo, P., Cappuccio, F. P., Trégouët, D., Lauria, F., Loguercio, M., Barba, G., Versiero, M., & Siani, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2523 · Cited by 108
Herling, A. W., Kilp, S., Elvert, R., Haschke, G., & Kramer, W. (2008) · Endocrinology · doi:10.1210/en.2007-1515 · Cited by 108
Prolonged glucocorticoid treatment decreases cannabinoid CB 1 receptor density in the hippocampus
Hill, M. N., Carrier, E. J., Ho, W. ‐. V., Shi, L., Patel, S., Gorzalka, B. B., & Hillard, C. J. (2007) · Hippocampus · doi:10.1002/hipo.20386 · Cited by 107
Yan, Z. C., Liu, D. Y., Zhang, L. L., Shen, C., Li, Q., Cao, T. B., Wang, L., Nie, H., Zidek, W., Tepel, M., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.213 · Cited by 106
Identification of Endocannabinoids and Related Compounds in Human Fat Cells
Gonthier, M., Hoareau, L., Festy, F., Matias, I., Valenti, M., Bès-Houtmann, S., Rouch, C., Silva, C. R. D., Chesne, S., d’Hellencourt, C. L., et al. (2007) · Obesity · doi:10.1038/oby.2007.581 · Cited by 88
Understanding Metabolic Homeostasis and Imbalance: What Is the Role of the Endocannabinoid System?
Kunos, G. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.007 · Cited by 81
Gazzerro, P., Caruso, M. G., Notarnicola, M., Misciagna, G., Guerra, V., Laezza, C., & Bifulco, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803510 · Cited by 76
Ruilope, L. M., Després, J., Scheen, A. J., Pi‐Sunyer, X., Mancia, G., Zanchetti, A., & Gaal, L. V. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f2d625 · Cited by 70
Bisogno, T., & Marzo, V. D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.002 · Cited by 68
Jensen, D. P., Andreasen, C. H., Andersen, M. K., Hansen, L., Eiberg, H., Borch‐Johnsen, K., Jørgensen, T., Hansen, T. F., & Pedersen, O. B. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0139-0 · Cited by 68
Perwitz, N., Faßhauer, M., & Klein, J. C. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-925401 · Cited by 66
Peeters, A. V., Beckers, S., Mertens, I. L., Hul, W. V., & Gaal, L. V. (2007) · Endocrine · doi:10.1007/s12020-007-0022-y · Cited by 62
Murdolo, G., Kempf, K., Hammarstedt, A., Herder, C., Smith, U., & Jansson, P. A. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347440 · Cited by 58
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases
Bellocchio, L., MANCINI, G., Vicennati, V., Pasquali, R., & Pagotto, U. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.09.001 · Cited by 53
Löfgren, P., Sjölin, E., Wåhlén, K., & Hoffstedt, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2240 · Cited by 52
Immune-mediated Activation of the Endocannabinoid System in Visceral Adipose Tissue in Obesity
Kempf, K., Hector, J. S., Strate, T. G., Schwarzloh, B., Rose, B., Herder, C., Martin, S., & Algenstaedt, P. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-984459 · Cited by 47
Müller, T. D., Reichwald, K., Wermter, A., Brönner, G., Nguyen, T. T., Friedel, S., Koberwitz, K., Engeli, S., Lichtner, P., Meitinger, T., et al. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.01.002 · Cited by 43
Herling, A. W., Gossel, M., Haschke, G., Stengelin, S., Kuhlmann, J., Müller, G. A., Schmoll, D., & Kramer, W. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00264.2007 · Cited by 42
Ruilope, L. M. (2008) · Journal of Hypertension · doi:10.1097/01.hjh.0000320755.15862.b2 · Cited by 12
Rimonabant: New data and emerging experience
Wright, S. M., Dikkers, C., & Aronne, L. J. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0011-5 · Cited by 11
Cited by
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties
Fidyt, K., Fiedorowicz, A., Strządała, L., & Szumny, A. (2016) · Cancer Medicine · doi:10.1002/cam4.816 · Cited by 674
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Silvestri, C., & Di Marzo, V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.001 · Cited by 543
Self-citation
Metadata
- Authors
- Di Marzo, V.
- Venue
- Diabetologia
- Published
- 2008-06-18
- Volume
- 51
- Issue
- 8
- Pages
- 1356-1367
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2136608474
- Cited by
- 281
- References
- 80
- FWCI
- 19.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.